204 related articles for article (PubMed ID: 31373701)
1. Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo.
Cook RL; Zhou Z; Miguez MJ; Quiros C; Espinoza L; Lewis JE; Brumback B; Bryant K
Alcohol Clin Exp Res; 2019 Aug; 43(8):1790-1800. PubMed ID: 31373701
[TBL] [Abstract][Full Text] [Related]
2. Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results.
Cook RL; Weber KM; Mai D; Thoma K; Hu X; Brumback B; Karki M; Bryant K; Rathore M; Young M; Cohen M
Contemp Clin Trials; 2017 Sep; 60():72-77. PubMed ID: 28642209
[TBL] [Abstract][Full Text] [Related]
3. Secondary Analysis of a Randomized Clinical Trial of Naltrexone Among Women Living With HIV: Correlations Between Reductions in Self-Reported Alcohol Use and Changes in Phosphatidylethanol.
Richards VL; Sajdeya R; Villalba K; Wang Y; Bryant V; Brumback B; Bryant K; Hahn JA; Cook RL
Alcohol Clin Exp Res; 2021 Jan; 45(1):174-180. PubMed ID: 33190242
[TBL] [Abstract][Full Text] [Related]
4. Impact of Reduction in Drinking vs. complete Cessation on the Severity and Type of Alcohol-Related Problems in Women Living with HIV.
Richards VL; Zhou Z; Wang Y; Vaddiparti K; Brumback B; Cook RL
Subst Use Misuse; 2021; 56(5):704-710. PubMed ID: 33682614
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
[TBL] [Abstract][Full Text] [Related]
7. Does treating pain with alcohol affect drinking reduction among women with HIV enrolled in a clinical trial of naltrexone?
Parisi CE; Gracy HR; Bush NJ; Cook RL; Wang Y; Chichetto N
Alcohol Clin Exp Res (Hoboken); 2023 Oct; 47(10):1917-1925. PubMed ID: 37864537
[TBL] [Abstract][Full Text] [Related]
8. Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.
Krupitsky E; Blokhina E; Zvartau E; Verbitskaya E; Lioznov D; Yaroslavtseva T; Palatkin V; Vetrova M; Bushara N; Burakov A; Masalov D; Mamontova O; Langleben D; Poole S; Gross R; Woody G
Lancet HIV; 2019 Apr; 6(4):e221-e229. PubMed ID: 30880163
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial.
Edelman EJ; Moore BA; Holt SR; Hansen N; Kyriakides TC; Virata M; Brown ST; Justice AC; Bryant KJ; Fiellin DA; Fiellin LE
AIDS Behav; 2019 Jan; 23(1):211-221. PubMed ID: 30073637
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.
Wang Y; Chen X; Hahn JA; Brumback B; Zhou Z; Miguez MJ; Cook RL
Alcohol Clin Exp Res; 2018 Jan; 42(1):128-134. PubMed ID: 29080351
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of Naltrexone for Attenuating Alcohol Consumption in Women with Alcohol Use Disorders.
Canidate SS; Carnaby GD; Cook CL; Cook RL
Alcohol Clin Exp Res; 2017 Mar; 41(3):466-472. PubMed ID: 28247556
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
Fridberg DJ; Cao D; Grant JE; King AC
Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
[TBL] [Abstract][Full Text] [Related]
13. Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.
Springer SA; Di Paola A; Azar MM; Barbour R; Krishnan A; Altice FL
Drug Alcohol Depend; 2017 May; 174():158-170. PubMed ID: 28334661
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia.
Shin S; Livchits V; Connery HS; Shields A; Yanov S; Yanova G; Fitzmaurice GM; Nelson AK; Greenfield SF;
Addiction; 2013 Aug; 108(8):1387-96. PubMed ID: 23490304
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
[TBL] [Abstract][Full Text] [Related]
16. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.
Anton RF; Latham PK; Voronin KE; Randall PK; Book SW; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2018 Apr; 42(4):751-760. PubMed ID: 29431852
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
[TBL] [Abstract][Full Text] [Related]
18. Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data.
Satre DD; Sarovar V; Leyden W; Hare CB; Catz SL; Bryant KJ; Williams EC; Hojilla JC; Horberg MA; Silverberg MJ
AIDS Behav; 2020 Jun; 24(6):1784-1792. PubMed ID: 31773444
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
[TBL] [Abstract][Full Text] [Related]
20. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
